Cleared Traditional

K781467 - U-FLOAT VALVE 2D9023

K781467 is the FDA 510(k) clearance for U-FLOAT VALVE 2D9023 by Travenol Laboratories, S.A.. It is a Class 2 Anesthesiology device (product code CAF) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K781467 · Travenol Laboratories, S.A. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1978
Decision
14d
Days
Class 2
Risk

K781467 is an FDA 510(k) clearance for the U-FLOAT VALVE 2D9023. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Travenol Laboratories, S.A. (Walker, US). The FDA issued a Cleared decision on September 7, 1978 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Travenol Laboratories, S.A. devices

Submission Details

510(k) Number K781467 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 24, 1978
Decision Date September 07, 1978
Days to Decision 14 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
126d faster than avg
Panel avg: 140d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 134
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K781467.
MANIFOLD, UNIVERSAL I.P.P.B
K790152 · Airlife, Inc. · Mar 1979
MANIFOLD, W/CORRUGATED TUBING
K790153 · Airlife, Inc. · Mar 1979
MANIFOLD, FOR DOUBLE SUPPLY
K790154 · Airlife, Inc. · Mar 1979
SOLUTIONS FOR RESPIRATORY THERAPY
K780668 · Travenol Laboratories, S.A. · Jun 1978
2C7153 NEBULIZER CAP
K780406 · Travenol Laboratories, S.A. · Apr 1978
NEBULIZER HEATER
K780456 · Travenol Laboratories, S.A. · Apr 1978